Genetic studies of founder effect have concentrated on discovering ancestral and novel genetic diseases caused by founder effect and, to a lesser degree, on ancestry-related founder effects on populations, races, and ancient migrations, as well as other aspects. The founder population could be the common ancestry of race or ethnicity or the forced localizations caused by artificial countries inside the larger group of ancestry, hence causing an original founder effect. Race and specific founder effect mutation diseases are found in all races or ethnicities, and country-specific mutation diseases are caused by increasing
homozygosity (the existence of same gene on both chromosomes pairs, hence a recessive disease may increase in just few generations). The genetic abnormality will increase incrementally with the decrease of number of isolated populations making tribe-specific diseases (such as
Ashkenazi Jews,
Amish, and
Bedouins) and novel genetic defects. In recessive diseases, founder populations where underlying levels of genome-wide homozygosity are high due to shared common ancestry, but also for consanguineous populations that will have large genome-wide homozygous regions due to inbreeding. Having a catalog of disease-associated variation in these populations enables rapid, early, and accurate diagnoses that may improve patient outcomes due to informed clinical management and early interventions. Enclosed communities such as Amish communities, Ashkenazi communities, and relatively isolated islands allow scientists to better understand and further discover the mutated genes that cause these rare diseases and allow them to also discover protective genes as well. Due to various migrations throughout human history, founder effects are somewhat common among humans in different times and places. The
French Canadians of
Quebec are a classical example of founder population. Over 150 years of French colonization, between 1608 and 1760, an estimated 8,500 pioneers married and left at least one descendant on the territory. Following the takeover of the colony by the British crown in 1760, immigration from France effectively stopped, but descendants of French settlers continued to grow in number mainly due to their high fertility rate. Intermarriage occurred mostly with the deported
Acadians and migrants coming from the British Isles. Since the 20th century, immigration in Quebec and mixing of French Canadians involve people from all over the world. While the French Canadians of Quebec today may be partly of other ancestries, the genetic contribution of the original French founders is predominant, explaining about 90% of regional gene pools, while Acadian (descended from other French settlers in eastern Canada) admixtures contributing 4% British and 2% Native American and other groups contributing less. The founder effect can also be observed among some communities of the
Romani people, an
Indo-Aryan ethnic group, which numbers approximately 8-10 million people in Europe, and additional numbers in other parts of the world, such as the United States and Latin America, and who were traditionally a
nomadic population. In humans, founder effects can arise from cultural isolation, and inevitably,
endogamy. For example, the Amish populations in the United States exhibit founder effects because they have grown from a very few founders, have not recruited newcomers, and tend to marry within the community. Though still rare, phenomena such as
polydactyly (extra fingers and toes, a symptom of a condition such as The island of
Pingelap also suffered a population bottleneck in 1775 following a typhoon that had reduced the population to only 20 people. As a result, complete
achromatopsia has a current rate of occurrence of roughly 10%, with an additional 30% being carriers of this recessive condition. Around 1814, a small group of British colonists founded a settlement on
Tristan da Cunha, a group of small islands in the Atlantic Ocean, midway between Africa and South America. One of the early colonists apparently carried a rare, recessive allele for
retinitis pigmentosa, a progressive form of blindness that afflicts
homozygous individuals. As late as 1961, the majority of the genes in the gene pool on Tristan were still derived from 15 original ancestors; as a consequence of the inbreeding, of 232 people tested in 1961, four were suffering from retinitis pigmentosa. This represents a prevalence of 1 in 58, compared with a worldwide prevalence of around 1 in 4,000. The abnormally high rate of twin births in
Cândido Godói could be explained by the founder effect. On 31 August 2023, researchers reported, based on genetic studies, that a
human ancestor population bottleneck (from a possible 100,000 to 1000 individuals) occurred "around 930,000 and 813,000 years ago ... lasted for about 117,000 years and brought human ancestors close to extinction." ==See also==